Logo

Intrinsic Bioprobes Wins US Patent for High-Throughput Proteomics Technology

Jul 31, 2003

NEW YORK, July 31 - Intrinsic Bioprobes, of Tempe, Ariz., has won a patent in the United States for its "bioactive chip" technology, the company said today.

 

US patent No. 6,569,383 covers the use of a single bioactive chip to prepare samples for high-throughput protein analysis, "particularly through advantageous techniques of analyte isolation, modification, and concentration," Intrinsic said.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.